InforCapital

Venture Capital Firms in Shanghai

16 investors found

Browse 16 Venture Capital Firms in Shanghai. Discover top investors, their portfolios, AUM, and investment focus on InforCapital.

Bosch Ventures

Bosch Ventures

InvestorChina200M AUM

Bosch Ventures, officially known as Robert Bosch Venture Capital GmbH (RBVC), is the corporate venture capital arm of the Bosch Group. Established in 2007, RBVC invests globally in innovative startups across all stages of development, focusing on technologies that are strategically significant to Bosch's future. RBVC's investment portfolio encompasses sectors such as automation, electrification, energy efficiency, enabling technologies, and healthcare systems. By leveraging Bosch's extensive global network and industry expertise, RBVC provides not only capital but also strategic support to its portfolio companies, fostering growth and innovation. With offices in Germany, the United States, Israel, and China, RBVC maintains a strong international presence. The firm typically invests between €500,000 and €10 million per company, with total assets under management exceeding €200 million.

Cathay Innovation

Cathay Innovation

InvestorChina2.8B AUM

Founded in 2015 by Mingpo Cai and Denis Barrier, Cathay Innovation is a global venture capital firm affiliated with Cathay Capital. The firm focuses on multi-stage investments in innovative startups across sectors such as artificial intelligence, fintech, digital health, consumer technology, and energy. With offices spanning North America, Europe, Asia, and Latin America, it leverages a global network to support founders in scaling their ventures internationally. In 2025, Cathay Innovation launched its largest fund to date—Fund III, a $1 billion investment vehicle focused on AI startups. The fund targets application-layer innovations in digital health, consumer apps, fintech, and energy/mobility. Strategic LPs include leading corporates such as Sanofi, TotalEnergies, and BNP Paribas Cardif, reinforcing the firm’s strong links between venture investment and corporate innovation. The firm invests from Series A to late-stage rounds with check sizes ranging from $5 million to $80 million. Already backing 14 companies through Fund III, including Nabla and Mogic AI, Cathay Innovation unites startups, investors, and corporates to deliver strategic growth. Its hybrid global-local model ensures unique market access and operational support to portfolio companies worldwide.

Centurium Capital

Centurium Capital

InvestorChina7.0B AUM

Centurium Capital (大钲资本) is a leading Chinese private equity investment firm headquartered in Beijing, with additional offices in Shanghai, Xiamen, and Hong Kong. The firm is dedicated to driving transformative change through its investments, focusing on building industry leaders with sustainable business models and competitive advantages. Centurium Capital emphasizes deep industry understanding and extensive resources within its core sectors, aiming to reshape industry ecosystems.The firm was co-founded in 2017 by David Li, formerly the Head of Asia Pacific at Warburg Pincus, along with two other partners. Li's vision was to establish a best-in-class private equity firm in China, combining international private equity best practices with deep local market expertise. Centurium Capital manages both RMB and USD funds, employing flexible investment strategies that span early, mid-to-late stage, and M&A/controlling stake opportunities. The firm is also a signatory of the United Nations-supported Principles for Responsible Investment (PRI), underscoring its commitment to integrating environmental, social, and governance (ESG) factors into its investment process and operations.Centurium Capital focuses its investments across several key sectors, including healthcare, hard technology, consumer, and enterprise services. Its diverse portfolio includes notable companies such as Luckin Coffee, a prominent new retail coffee chain; Seyond (图达通), a global leader in image-grade LiDAR solutions; Xiaopeng Motors, a leading smart electric vehicle designer and manufacturer; and Taibang Bio Group, a major blood products producer. The firm also holds investments in companies like Aneng Logistics, Fadaada (electronic contract services), and Ruhlamat, a smart manufacturing player.The firm operates with a hands-on, operation-centric "Invest to Transform" model, providing tailored solutions to portfolio companies and management teams. Centurium Capital's team comprises professionals with rich and complementary experience across private equity investment, corporate finance, M&A, corporate management, operations, and strategic consulting. This expertise allows them to offer long-term value-added services, helping companies formulate effective business strategies, enhance operational efficiency, and drive growth and industry transformation.

Eight Roads

Eight Roads

InvestorChina11.0B AUM

Eight Roads is a global investment firm that manages over $11 billion of assets, with a strong focus on partnering with ambitious entrepreneurs to build transformational businesses. With a legacy of over 50 years, the firm operates as a long-term capital partner, offering more than just funding by providing strategic support, deep sector expertise, and a broad global network.The firm specializes in growth-stage investments, backing innovative companies in healthcare, technology, and consumer sectors. Eight Roads is known for its operational insight and collaborative approach, often taking an active role in helping portfolio companies scale and succeed in competitive markets.With offices in Europe, India, China, Japan, and the US, Eight Roads leverages a truly global perspective while tailoring support to local contexts. Its mission is to empower businesses that challenge the status quo and create long-lasting impact across industries and geographies.

HongShan Capital Group

HongShan Capital Group

InvestorChina56.0B AUM

HongShan Capital Group is a prominent investment firm with a strong focus on innovation-driven sectors such as technology, consumer, and healthcare. Originating from its legacy as Sequoia Capital China, HongShan has established itself as a separate and independent entity, continuing to support visionary entrepreneurs from startup to scale. With a rich history of identifying and backing transformative companies, HongShan is known for its long-term commitment to fostering sustainable growth. The firm provides a wide range of investment strategies including venture capital, growth equity, and private equity, offering both financial and strategic support. With deep industry knowledge and local expertise, HongShan is adept at navigating complex markets and delivering value across different stages of a company's lifecycle. Its investment philosophy combines rigorous analysis with a hands-on approach to portfolio management, enabling high-impact outcomes. Headquartered in Asia, HongShan Capital Group operates a global platform with a strong presence in China, Southeast Asia, and the United States. Its cross-border capabilities allow it to support entrepreneurs building globally competitive businesses. The firm continues to be a preferred partner for ambitious founders seeking capital and strategic guidance to scale their ventures.

HSG

HSG

InvestorChina56.0B AUM

HSG (HongShan Capital Group), formerly known as Sequoia Capital China, is a premier global venture capital and private equity firm founded in 2005. With over two decades of experience, HSG has backed more than 1,600 companies featuring transformative technologies, disruptive business models, and high-growth potential. The firm has nurtured entrepreneurship and innovation across multiple stages of investment, including seed, venture, growth, buyout, and infrastructure, managing approximately $56 billion in assets.Headquartered in Hong Kong, HSG operates offices in Beijing, Shanghai, Shenzhen, Singapore, London, and Tokyo, serving a global client base of top institutional investors such as sovereign wealth funds, foundations, pension funds, corporations, and family offices. Its portfolio companies collectively serve billions of customers in over 150 countries, with more than 160 companies having gone public and over 140 achieving unicorn status.HSG is committed to helping founders build enduring, legendary companies while delivering superior returns to its limited partners. The firm leverages extensive resources, including a robust entrepreneurial community and deep industry expertise, to support its portfolio companies.

Kleiner Perkins

Kleiner Perkins

InvestorChina10.8B AUM

Kleiner Perkins, founded in 1972 by Eugene Kleiner and Tom Perkins, is a renowned venture capital firm based in Menlo Park, California. With a legacy of backing pioneering companies like Amazon, Google, and Genentech, the firm has been instrumental in shaping the technology landscape. Over the decades, Kleiner Perkins has invested in over 900 ventures, focusing on early-stage and growth-stage companies that drive innovation across various sectors. The firm's investment strategy encompasses a broad range of industries, including technology, healthcare, life sciences, and sustainability. Kleiner Perkins is known for its hands-on approach, partnering closely with entrepreneurs to provide not only capital but also strategic guidance and operational support. This collaborative model has led to numerous successful exits, including IPOs and acquisitions, solidifying its reputation as a top-tier venture capital firm. With offices in Menlo Park, San Francisco, and Shanghai, Kleiner Perkins maintains a global presence to support its diverse portfolio. The firm's commitment to fostering groundbreaking ideas and its track record of successful investments continue to attract visionary founders seeking to make a significant impact in their respective industries.

Lightspeed Venture Partners

Lightspeed Venture Partners

InvestorChina28.2B AUM

Lightspeed Venture Partners is a global venture capital firm founded in 2000, specializing in multi-stage investments across enterprise, consumer, fintech, and healthcare sectors. With a mission to accelerate disruptive innovations, Lightspeed has backed over 500 companies worldwide, including notable names like Snap, Affirm, and Nutanix. The firm's collaborative approach and deep industry expertise have positioned it as a trusted partner for entrepreneurs aiming to build impactful businesses. Operating from 14 offices across the United States, Europe, Asia, and Israel, Lightspeed maintains a strong global presence. This extensive network enables the firm to identify and support promising startups in diverse markets. By providing not only capital but also strategic guidance, Lightspeed helps its portfolio companies navigate the challenges of scaling and innovation. As of 2025, Lightspeed manages approximately $28.2 billion in assets under management, reflecting its significant role in the venture capital landscape. The firm's commitment to fostering innovation and long-term partnerships continues to drive its success in supporting the next generation of industry leaders.

Lilly Asia Ventures (LAV)

Lilly Asia Ventures (LAV)

InvestorChina4.5B AUM

Lilly Asia Ventures is a prominent venture capital firm that specializes in investing in innovative healthcare companies across Asia. Founded in 2008, the firm leverages its deep industry expertise and extensive network to identify and support high-potential startups and growth-stage companies in the life sciences sector. With a strong focus on biotechnology, pharmaceuticals, and medical devices, Lilly Asia Ventures aims to drive advancements in healthcare by providing not only capital but also strategic guidance to its portfolio companies. The firm is committed to fostering innovation and improving patient outcomes through its investments. Over the years, Lilly Asia Ventures has built a diverse portfolio of companies that are at the forefront of medical research and technology. The firm prides itself on its collaborative approach, working closely with entrepreneurs and management teams to help them achieve their vision and scale their businesses effectively. As of the latest updates, Lilly Asia Ventures manages approximately $4.5 billion in assets, reflecting its strong position in the venture capital landscape. The firm is headquartered in Shanghai, China, and has a dedicated team of professionals with extensive experience in both investment and healthcare.

NGP Capital

NGP Capital

InvestorChina1.6B AUM

NGP Capital is a global venture capital firm founded in 2005, dedicated to partnering with exceptional founders to transform innovative ideas into impactful companies. The firm specializes in backing early to growth-stage B2B companies that drive the convergence of the physical and digital worlds, focusing on sectors such as enterprise software, industrial technology, cybersecurity, and infrastructure.With over $1.6 billion in assets under management, NGP Capital has made 175 investments and achieved 56 portfolio exits, including 19 unicorns and 11 IPOs. The firm emphasizes long-term, loyal partnerships with founders, providing not only capital but also strategic guidance, deep industry expertise, and access to extensive networks.Their investment approach is data-driven and powered by proprietary AI tools to identify promising opportunities and support portfolio growth. NGP Capital operates globally with teams based in Palo Alto (USA), Berlin (Germany), and Helsinki (Finland), investing primarily across Europe, Israel, and the United States, with occasional investments in other regions. The firm typically invests in Series A through Series C rounds, with initial ticket sizes ranging from $5 million to $15 million, often leading or co-leading rounds between $10 million and $50 million in total.NGP Capital's mission is to help founders scale internationally and create companies that shape a better future.

Prosperity7 Ventures

Prosperity7 Ventures

InvestorChina3.0B AUM

Prosperity7 Ventures is the diversified growth fund of Aramco Ventures, a subsidiary of Aramco, the world’s leading integrated energy and chemicals company. Headquartered in Dhahran, Saudi Arabia, Prosperity7 invests globally with a long-term view, supporting the development of next-generation technologies and business models that drive global transformation and prosperity. The fund’s name is inspired by the Prosperity Well, the seventh oil well drilled in Saudi Arabia and the first to strike oil, symbolizing a legacy of pioneering innovation and perseverance. With a $3 billion fund size, Prosperity7 provides venture capital, mentorship, and access to a global network of experts and partners. The firm supports startups across a wide range of industries, including DeepTech, Robotics/AI, MedTech/BioTech, Mobility, SecurityTech, FinTech, eCommerce, Cloud/Computing, and Foodtech. Prosperity7’s offices in Dhahran, Beijing, Shanghai, New York City, and San Francisco enable it to offer local knowledge, connections, and market access to its portfolio companies, helping them scale quickly and enter new markets. Prosperity7 is known for its entrepreneurial mindset, long-term partnerships, and commitment to solving some of the world’s toughest problems. The firm’s values of dependability, humility, and open-mindedness guide its approach to investing and supporting founders. By backing exceptional entrepreneurs and providing access to global markets, Prosperity7 aims to create lasting positive impact and drive innovation on a vast scale.

Redpoint Ventures

Redpoint Ventures

InvestorChina4.0B AUM

Redpoint Ventures, founded in 1999, is a renowned global venture capital firm headquartered in Menlo Park, California. With additional offices in San Francisco, Los Angeles, Beijing, and Shanghai, the firm partners with exceptional entrepreneurs to build market-leading companies that redefine the future of technology. The firm invests across seed, early, and growth stages in a wide array of sectors, including enterprise software, fintech, consumer internet, and digital health. Redpoint has backed over 465 companies, with standout investments in iconic names such as Netflix, Twilio, Snowflake, Stripe, and HashiCorp, demonstrating its track record of identifying and supporting high-potential ventures. With over $4 billion in assets under management, Redpoint provides not just capital but strategic guidance and access to a deep network of industry leaders. The firm is known for its long-term support and deep commitment to innovation and scalable growth across global markets.

Sequoia Capital

Sequoia Capital

InvestorChina85.0B AUM

Sequoia Capital is a premier venture capital firm founded in 1972 by Don Valentine in Menlo Park, California. With a mission to partner with visionary founders, Sequoia has played a pivotal role in the growth of iconic companies like Apple, Google, Airbnb, and WhatsApp. The firm's enduring commitment to innovation has solidified its reputation as a cornerstone of Silicon Valley's entrepreneurial ecosystem. Operating globally, Sequoia Capital maintains offices in the United States, China, India, Israel, and the United Kingdom. This expansive presence enables the firm to identify and support promising startups across diverse markets. Sequoia's investment approach is characterized by deep partnerships, providing not only capital but also strategic guidance to help companies navigate their growth trajectories. Sequoia's investment portfolio spans various sectors, including technology, healthcare, financial services, and consumer products. The firm's assets under management have reached approximately $85 billion, reflecting its significant influence in the venture capital landscape. With a team of experienced professionals, Sequoia continues to foster innovation and drive success for its portfolio companies worldwide.

Shanda Grab Ventures

Shanda Grab Ventures

InvestorChina8.0B AUM

Shanda Group is a privately-owned multinational investment firm established in 1999 by Tianqiao Chen and Chrissy Luo. Originally founded as Shanda Interactive Entertainment, a pioneering online gaming company in China, it has evolved into a diversified investment group with a global presence. The firm operates offices in Shanghai, Singapore, Hong Kong, New York, Menlo Park, and Redwood City, focusing on investments in public markets, venture capital, private equity, and real estate. Shanda's investment strategy targets disruptive, human-oriented deep technologies, including gene-editing, robotics, anti-aging, brain-related neuroscience, and artificial intelligence. The firm has invested in over 75 early-stage venture capital funds and directly in numerous startups worldwide. Its real estate portfolio includes developments in China and significant timberland holdings in North America. Additionally, Shanda emphasizes social responsibility and philanthropy through the Tianqiao and Chrissy Chen Institute, which focuses on brain science research. With approximately $8 billion in assets under management, Shanda combines entrepreneurial vision with rigorous investment acumen. The firm’s diversified portfolio spans healthcare, financial services, media, technology, and real estate sectors, with a geographic focus on North America, China, Singapore, Hong Kong, and other global markets. Shanda continues to innovate by investing in early-stage deep tech ventures and undervalued public companies with turnaround potential.

TF Capital

TF Capital

InvestorChina1.0B AUM

TF Capital is a venture capital firm headquartered in Shanghai, China, specializing in early-stage investments in the life sciences sector. Founded in 2013, the firm targets category-defining companies in biotechnology, therapeutics, pharmaceuticals, and related fields, providing not only capital but also strategic support through its network of advisors, industrialists, and tech leaders, particularly in the Asia Pacific region. The firm emphasizes full value-chain support, from proprietary sourcing and partnerships with listed companies and clinical experts to facilitating license-out deals generating over $2B in upfronts from 18 transactions across 11 companies. With a portfolio exceeding 100 companies, 20 IPOs, and 94 investments documented, TF Capital has backed notable exits like Zai Lab and Structure Therapeutics, focusing on preclinical, clinical-stage, and growth opportunities in pharma R&D and biomedical technology. TF Capital manages three funds, including Shanghai Taiyi Venture Investment Fund LP, and maintains a global outlook while prioritizing China-based innovation. Its team combines deep domain expertise with active involvement in go-to-market strategies, capital partnerships, and market insights to accelerate portfolio scaling in dynamic regions.

Two Sigma Ventures

Two Sigma Ventures

InvestorUnited States

Two Sigma Ventures is the venture capital arm of Two Sigma Investments, LP, a prominent financial sciences company. The firm focuses on early to growth-stage companies that leverage data science, machine learning, and advanced computing to create transformative solutions across various industries. Their investment thesis centers on the belief that as the world becomes increasingly information-rich, innovative companies will harness these technological advancements to develop breakthrough solutions. Two Sigma Ventures actively invests in sectors such as enterprise software, financial technology (fintech), techbio and life sciences, healthcare technology, consumer technology, Web3 and crypto, developer tools and infrastructure, security and cybersecurity, real estate technology (PropTech), insurance technology, and AI/ML infrastructure.Founded in 2011, Two Sigma Ventures emerged from the broader Two Sigma organization, drawing upon its deep legacy in quantitative research and technology. Colin Beirne, a key partner, was instrumental in launching the venture capital arm. The firm's approach is rooted in applying scientific rigor and data analysis, mirroring the methodologies that have driven success in its parent company's investment management business. This foundation allows Two Sigma Ventures to provide not just capital, but also institutional-grade expertise and hands-on support in areas like data science, software engineering, and product development to its portfolio companies.The firm has built a diverse portfolio of over 100 companies, demonstrating its commitment to data-driven innovation. Notable investments and successful exits include Recursion Pharmaceuticals (AI-driven drug discovery), WHOOP (wearable health technology), GitLab (DevOps platform), and Remote (distributed workforce management). Other significant portfolio companies include CoverWallet, Carbon Health, Insitro, Timescale, and Wealthsimple. Recent investments in 2025 include Bedrock Robotics and NetBox Labs, showcasing their continued activity in cutting-edge technologies.The Two Sigma Ventures team comprises a blend of entrepreneurs, data scientists, mathematicians, and operators. Key partners include Colin Beirne, Dusan Perovic, Dan Abelon, Sidney Costabile, and Frances Schwiep, alongside principals like Joe Botsch. The investment team is supported by the extensive technical network and expertise of the broader Two Sigma ecosystem, which includes over 250 PhDs and a wealth of experience in software engineering, data science, quantitative modeling, and machine learning. This collective intelligence provides a unique advantage in identifying and nurturing companies that are pushing the boundaries of technology and data.

You reached the end.

Understanding Venture Capital Firms in Shanghai

Shanghai, known as China's financial powerhouse, is home to a burgeoning venture capital scene. With a dynamic economy and a strategic position as a gateway to both domestic and international markets, Shanghai attracts a myriad of venture capital firms. This curated directory highlights 14 prominent investors operating in the city, offering a glimpse into the investment landscape that defines Shanghai's venture capital ecosystem.

Investment Strategies of Shanghai Venture Capital Firms

Venture capital firms in Shanghai typically adopt innovative investment strategies aimed at identifying and nurturing high-potential startups. These firms often focus on early-stage investments, seeking opportunities in industries such as technology, healthcare, and consumer goods. By leveraging their deep understanding of the local market dynamics, these investors provide not just capital but also strategic guidance to emerging businesses.

Sector Focus and Investment Preferences

The sectoral focus of these venture capital firms is diverse, reflecting Shanghai's multifaceted economy. Technology-driven sectors, including fintech, artificial intelligence, and e-commerce, are particularly attractive, given their rapid growth and transformative potential. Additionally, healthcare startups focusing on biotechnology and medical devices are gaining traction, aligning with global trends towards innovation in health services.

Geographic Reach and Expansion

While Shanghai-based venture capital firms maintain a strong local presence, their investment reach often extends beyond China's borders. Many firms actively seek opportunities across Asia, leveraging Shanghai's strategic position to access regional markets. This geographic diversification allows them to mitigate risks and tap into emerging trends in neighboring economies.

Importance for Limited Partners and Deal Professionals

For limited partners (LPs) and deal professionals, understanding the landscape of venture capital firms in Shanghai is crucial. These investors are instrumental in driving innovation and economic growth, making them attractive partners for those seeking exposure to China's dynamic startup ecosystem.

Partnership Opportunities and Network Expansion

Engaging with venture capital firms in Shanghai presents significant opportunities for LPs looking to diversify their investment portfolios. These firms often have access to proprietary deal flow and possess the expertise to identify promising ventures at an early stage. For deal professionals, partnering with these investors can enhance their network and facilitate entry into high-growth sectors.

Risk Management and Strategic Insights

Shanghai's venture capital firms offer valuable strategic insights and risk management capabilities, essential for navigating the complexities of the Chinese market. Their local expertise and understanding of regulatory nuances provide LPs and deal professionals with a competitive edge, enabling informed investment decisions.

Conclusion

The venture capital landscape in Shanghai is marked by a robust and diversified ecosystem, characterized by firms with a keen eye for innovation and growth. With a strategic focus on emerging sectors and a broader geographic reach, these investors play a pivotal role in shaping Shanghai's economic future. For LPs and deal professionals, engaging with these firms offers a gateway to capitalize on the myriad opportunities presented by China's thriving startup scene.